IX BIOPHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of 42C for the last semiannual is 3.29 M SGD, and it's 23.02% higher compared to the previous semiannual. The net income of H2 24 is -3.46 M SGD.